Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $26.3 million.

  • Celularity's Shares Outstanding (Weighted Average) rose 1989.18% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year increase of 1989.18%. This contributed to the annual value of $21.9 million for FY2024, which is 2289.04% up from last year.
  • Latest data reveals that Celularity reported Shares Outstanding (Weighted Average) of $26.3 million as of Q3 2025, which was up 1989.18% from $24.0 million recorded in Q2 2025.
  • Over the past 5 years, Celularity's Shares Outstanding (Weighted Average) peaked at $140.2 million during Q2 2022, and registered a low of $15.5 million during Q1 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $22.8 million (2024), whereas its average is $38.5 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 48415.79% in 2022, then crashed by 8808.54% in 2023.
  • Quarter analysis of 5 years shows Celularity's Shares Outstanding (Weighted Average) stood at $67.1 million in 2021, then soared by 109.0% to $140.2 million in 2022, then crashed by 87.29% to $17.8 million in 2023, then grew by 22.89% to $21.9 million in 2024, then grew by 20.36% to $26.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $26.3 million in Q3 2025, compared to $24.0 million in Q2 2025 and $23.5 million in Q1 2025.